View in browser


What year is it again? While the upcoming EuroMedLab 2021 congress might be outdated in name due to its corona-related postponement, its featured topics are anything but: we take a look at new developments in laboratory medicine, from POCT applications and standardisation of lab measurements, to the potential of medical big data. Enjoy reading!

Article • Point-of-care testing

POCT: a “win-win” scenario for all involved

Point-of-care testing (POCT) is a “win-win” scenario for patients and healthcare professionals in delivering care when and where it is needed, according to pathologist Adil Khan, MSc, PhD.

Article • AI and DL to drive precision medicine

Diving into medical big data

Big data is transforming diagnosis and medical care, but the critical challenge remains over how to equally apply the benefits it delivers across real-world clinical settings, according to industry expert Prof Benoît Macq.

Sponsored • Implants

Osteoconductive PEEK biomaterial for injection molding

The specialty chemicals company Evonik and the Swiss plastics specialist Samaplast are combining their expertise in the development of an osteoconductive PEEK biomaterial for injection molding.

News • Neurology

Biodegradable implant to monitor brain chemistry

A wireless sensor could offer doctors a way to monitor changes in brain chemistry without requiring a second operation to remove the implant.

Article • Standardisation in drug monitoring

How traceability eliminates lab-to-lab variability

The advantages and limitations of the value of traceability chains in therapeutic drug monitoring will be explored during a key session at the EuroMedLab event.

Article • Energy conservation & waste reduction

Reducing the eco-footprint of radiology

Contrast agents in the wastewater and power-hungry imaging systems: The eco-footprint of healthcare is huge, and radiology departments are among the main culprits. An expert panel at the ECR Overture explored ways to make the field “greener”.

News • Mammography evaluation

Breast cancer screening: AI shows promise

A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs.


Article • Research, diagnostics, therapy

Laboratory medicine in focus

Article • More than just a subdiscipline

Spotlight on clinical chemistry


You are receiving this email because you subscribed to our newsletter on healthcare-in-europe

If you don’t want to receive this newsletter anymore, click here to unsubscribe.

Keep up-to-date on the latest news from all hospital-related fields!
Subscribe to our bi-monthly newsletter.

Copyright © 2023 mgo fachverlage GmbH & Co. KG.
All rights reserved.

E.-C.-Baumann-Straße 5, 95326 Kulmbach, Germany